Determination of Trimethoprim and Sulfamethoxazole (co-trimoxazole) in Body Fluids of Man by Means of High-performance Liquid Chromatography
Overview
Affiliations
A high-performance liquid chromatographic method for the determination of trimethoprim, sulfamethoxazole and its metabolite and a series of structurally related sulfonamides is described. The half-life time of elimination of sulfamethoxazole and its metabolite N4-acetylsulfamethoxazole is 9 h for both compounds. The renal excretion rate of sulfamethoxazole depends strongly on the urinary pH. The renal excretion rate of the metabolite N4-acetylsulfamethoxazole is not dependent on the urinary pH.
Loffler P, Escher B, Baduel C, Virta M, Lai F Environ Sci Technol. 2023; 57(26):9474-9494.
PMID: 37335844 PMC: 10324322. DOI: 10.1021/acs.est.2c09854.
Perkins J, Parker C, Tomer K J Am Soc Mass Spectrom. 2013; 3(2):139-49.
PMID: 24242882 DOI: 10.1016/1044-0305(92)87047-3.
Sayar E, Sahin S, Cevheroglu S, Hincal A Eur J Drug Metab Pharmacokinet. 2011; 35(1-2):41-6.
PMID: 21495265 DOI: 10.1007/s13318-010-0006-9.
Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).
Patel R, Welling P Clin Pharmacokinet. 1980; 5(5):405-23.
PMID: 7408366 DOI: 10.2165/00003088-198005050-00001.
Determination of the acetylator phenotype and pharmacokinetics of some sulphonamides in man.
Vree T, OREILLY W, Hekster Y, Damsma J, van der Kleijn E Clin Pharmacokinet. 1980; 5(3):274-94.
PMID: 7389236 DOI: 10.2165/00003088-198005030-00006.